Are you interested in the latest developments in vaccinology, both in infectious diseases and in cancer? Want to learn about vaccine design, manufacture and clinical development through a combination of taught classes and practical workshops? We invite you to attend a 5-day joint Leiden University Medical Center (LUMC) and University of Oxford Summer School in Leiden.
- Start date 03-09-18
- Duration 5 days
- Level PhD/Master
- Location Leiden
- Course fee 200-900
This course builds on the successful University of Oxford Vaccinology Training program. Lectures will be given by world leaders and experts in vaccinology and will span all aspects of vaccine development from antigen discovery, preclinical testing, GMP manufacture and clinical evaluation as well as ethical and regulatory considerations. Course modules cover Microbial Vaccines, Cancer Vaccines, Clinical Development, Adjuvants and Manufacture.
The Themes covered by the Summer School can be summarized as follows:
- Introduction to vaccinology including the importance of vaccines in disease eradication and control; challenges faced in vaccinology, and new approaches to vaccine development;
- Infectious disease vaccine design and preclinical validation;
- Cancer vaccinology (therapeutic and prophylactic vaccines), and consideration of the challenges in developing a successful cancer immunotherapy;
- The clinical development pathway with examples of research stage and licensed vaccines;
- Specific examples of vaccines (illustrating key points which can be applied to other diseases);
- The use and role of adjuvants;
- GMP manufacture of vaccines and regulatory concerns;
- Ethical considerations in testing vaccines in clinical trials.
The objectives of the course are as follows:
- To develop an overall understanding of vaccine development from pre-clinical testing, through Phase I-IV clinical trials and licensure.
- To give participants the knowledge and skill to design and test a vaccine for a given disease, including understanding of the immune response required, need for an adjuvant, and optimal vaccine design, including target antigen(s) and choice of subunit versus whole organism.
- To impart knowledge and understanding of manufacture across a spectrum of different vaccines, including the requirements of GMP (Good Manufacturing Practice).
- To give an understanding of the approaches available in developing a successful cancer vaccine, including personalized cancer vaccines.
This Summer School is particularly suitable for PhD students, and for final year Master’s students as well as early stage post-doctoral scientists who have had exposure to one or more of the following; immunology, microbiology and oncology. The course is best suited for those interested in increasing their knowledge on human vaccine research, clinical development of vaccines, clinical trials as well the industrial production, testing and licensing of vaccines. While the course is directed at PhD/graduate students, scientists working in industry may also wish to apply to gain latest insights into vaccinology. The number of applicants in the course will not exceed 30.
The course welcomes applicants based in Universities, Research Institutes and in Industry, with PhD/Master’s students nearing the completion of their studies particularly encouraged to apply.
Academic rate: € 200,-
Industry rate: € 900,-
Fee covers: registration, breakfast, on-site meals, social program and network opportunities. The fee also covers the hotel accommodation for 5 days (based on 2 person sharing). Single occupancy supplement (€ 125,-).
Application is free of charge. Applicants will be required to send a 2 page CV that includes academic record and current employment. The student should provide a short (300 words or less) summary of their current research and a short (no more than 1 page) motivation letter, indicating why they would like to enrol in the course and what they hope to learn and gain from the Summer School. Please send these documents to email@example.com upon application (through the sign up button at the top or bottom of this page). Incomplete applications will not be taken into consideration.
Successful applicants will be notified by 7th July 2018.
- Erik Jansen